A citation-based method for searching scientific literature

Jennifer B Green, M Angelyn Bethel, Paul W Armstrong, John B Buse, Samuel S Engel, Jyotsna Garg, Robert Josse, Keith D Kaufman, Joerg Koglin, Scott Korn, John M Lachin, Darren K McGuire, Michael J Pencina, Eberhard Standl, Peter P Stein, Shailaja Suryawanshi, Frans Van de Werf, Eric D Peterson, Rury R Holman. N Engl J Med 2015
Times Cited: 1514



Mansoor Husain, Andreas L Birkenfeld, Morten Donsmark, Kathleen Dungan, Freddy G Eliaschewitz, Denise R Franco, Ole K Jeppesen, Ildiko Lingvay, Ofri Mosenzon, Sue D Pedersen, Cees J Tack, Mette Thomsen, Tina Vilsbøll, Mark L Warren, Stephen C Bain. N Engl J Med 2019
Times Cited: 403




List of shared articles



Times cited


Incretin drugs in diabetic kidney disease: biological mechanisms and clinical evidence.
Radica Z Alicic, Emily J Cox, Joshua J Neumiller, Katherine R Tuttle. Nat Rev Nephrol 2021
14



Therapies for the Treatment of Cardiovascular Disease Associated with Type 2 Diabetes and Dyslipidemia.
María Aguilar-Ballester, Gema Hurtado-Genovés, Alida Taberner-Cortés, Andrea Herrero-Cervera, Sergio Martínez-Hervás, Herminia González-Navarro. Int J Mol Sci 2021
3

Glucose-Lowering Medications and Cardiovascular Outcomes.
Madhan Shanmugasundaram, J R Exequiel Pineda, Sangeetha Murugapandian. Curr Cardiol Rep 2021
1

Effects of anti-diabetes medications on cardiovascular and kidney outcomes in Asian patients with type 2 diabetes: a rapid evidence assessment and narrative synthesis.
Takashi Kadowaki, Fumiko Yamamoto, Yusuke Taneda, Yusuke Naito, Douglas Clark, Søren S Lund, Tomoo Okamura, Kohei Kaku. Expert Opin Drug Saf 2021
0

Glucagon-like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefits-The role of the GLP-1 receptor.
Johanna Helmstädter, Karin Keppeler, Leonie Küster, Thomas Münzel, Andreas Daiber, Sebastian Steven. Br J Pharmacol 2021
1

Report from the CVOT Summit 2020: new cardiovascular and renal outcomes.
Oliver Schnell, Xavier Cos, Francesco Cosentino, Thomas Forst, Francesco Giorgino, Hiddo J L Heersprink, Mikhail Kosiborod, Christoph Wanner, Eberhard Standl. Cardiovasc Diabetol 2021
1

Diabetes Management in Patients with Heart Failure.
Jia Shen, Barry H Greenberg. Diabetes Metab J 2021
0

Cardiovascular Outcome Trials with Glucose-Lowering Drugs.
Tina K Thethi, Anika Bilal, Richard E Pratley. Curr Cardiol Rep 2021
1

CARDIOVASCULAR EFFECTS OF NON-INSULIN GLUCOSE-LOWERING AGENTS: A COMPREHENSIVE REVIEW OF TRIAL EVIDENCE AND POTENTIAL CARDIOPROTECTIVE MECHANISMS.
Gianluigi Savarese, Javed Butler, Lars H Lund, Deepak L Bhatt, Stefan D Anker. Cardiovasc Res 2021
0

Cardiovascular Outcomes Trials of Incretin-Based Therapies.
Tina K Thethi, Anika Bilal, Richard E Pratley. Diabetes Spectr 2021
0

JCS/JHFS 2021 Guideline Focused Update on Diagnosis and Treatment of Acute and Chronic Heart Failure.
Hiroyuki Tsutsui, Tomomi Ide, Hiroshi Ito, Yasuki Kihara, Koichiro Kinugawa, Shintaro Kinugawa, Miyuki Makaya, Toyoaki Murohara, Koichi Node, Yoshihiko Saito,[...]. J Card Fail 2021
0

Evolving Concepts of Type 2 Diabetes Management.
Layla A Abushamat, Jane E B Reusch. Med Clin North Am 2021
0

Blood Pressure-Lowering Effect of Newer Antihyperglycemic Agents (SGLT-2 Inhibitors, GLP-1 Receptor Agonists, and DPP-4 Inhibitors).
Charalampos I Liakos, Dimitrios P Papadopoulos, Elias A Sanidas, Maria I Markou, Erifili E Hatziagelaki, Charalampos A Grassos, Maria L Velliou, John D Barbetseas. Am J Cardiovasc Drugs 2021
1

Changing Fields-Diabetes Medications Invading the Cardiovascular Space.
Lauren D Breite, Mackenzie Steck, Brandon Tate Cutshall, Samarth P Shah, Brandon E Cave. Curr Probl Cardiol 2021
0

Optimizing Management of Type 2 Diabetes and Its Complications in Patients With Heart Failure.
Christie A Schumacher, Elizabeth K Van Dril, Kayce M Shealy, Jennifer D Goldman. Clin Diabetes 2021
0

Current Status and Potential Therapeutic Strategies for Using Non-coding RNA to Treat Diabetic Cardiomyopathy.
Amit K Rai, Brooke Lee, Ramesh Gomez, Deepu Rajendran, Mahmood Khan, Venkata Naga Srikanth Garikipati. Front Physiol 2021
1


Heart failure outcomes and glucagon-like peptide-1 receptor agonists: A systematic review of observational studies.
Omar S Alkhezi, Haifa A Alsuhaibani, Amal A Alhadyab, Mashael E Alfaifi, Basmah Alomrani, Ali Aldossary, Osamah M Alfayez. Prim Care Diabetes 2021
0

Interpretation of clinical trials on the cardiovascular effects of hypoglycemic drugs in people with type2 diabetes.
Ana Romero, Gemma Llauradó, José-Miguel González-Clemente. Endocrinol Diabetes Nutr (Engl Ed) 2021
0


Clinical Phenotypes in Patients With Type 2 Diabetes Mellitus: Characteristics, Cardiovascular Outcomes and Treatment Strategies.
Pishoy Gouda, Sijia Zheng, Tricia Peters, Marat Fudim, Varinder Kaur Randhawa, Justin Ezekowitz, Thomas A Mavrakanas, Nadia Giannetti, Michael Tsoukas, Renato Lopes,[...]. Curr Heart Fail Rep 2021
0